SDIC Innovation Investment Management
SDIC Fund Management, established in July 2009 and based in Beijing, is a prominent private equity and venture capital firm in China, associated with the State Development & Investment Corp., Ltd. The firm manages nearly 60 billion yuan in assets, drawing from a diverse range of sources, including financial institutions, social security funds, and both state-owned and private capital. SDIC Fund Management focuses its investments across various sectors, emphasizing mobile internet, cloud computing, big data, intelligent manufacturing, electric vehicles, healthcare, and advanced manufacturing technologies. It seeks to enhance productivity and growth within industries such as technology, media, and consumer services through its comprehensive asset management and investment strategies. With an additional office in Asia, the firm is recognized as one of the largest professional private equity institutions in the country.
Beijing Mabworks Biotech Co., Ltd. is a biotechnology company based in Beijing, China, specializing in the research and development of gene-engineered antibody drugs. Founded in 2003, Mabworks focuses on the discovery, development, manufacturing, and commercialization of therapeutic antibodies. The company’s portfolio includes several products, such as MIL77, an Ebola treatment, MIL60, a biosimilar to the cancer drug Bevacizumab, and MIL62, which targets chronic lymphocytic leukemia. Additionally, Mabworks is involved in the development of innovative antibody drugs aimed at addressing various cancers and autoimmune diseases, leveraging advances in immunology and cancer biology.
FitSAMO is an orthopaedic surgical equipment supplier.
TSC Laser Technology Development (Beijing) Co., Ltd. provides 3D printing services. The firm is headquartered in China.
RootCloud is a cloud computing platform based in Beijing, China, that focuses on industrial applications and the internet of things (IoT). Founded in 2016, it provides a comprehensive suite of services for machine manufacturers, equipment users, government agencies, and other organizations. The platform facilitates online management of industrial assets through a multi-layered architecture that includes connection, platform, and application layers. It offers solutions in areas such as smart manufacturing, research and development, energy management, and industrial artificial intelligence. RootCloud specializes in delivering IoT and big data services, enabling large-scale manufacturing enterprises to achieve digital transformation and improve operational efficiency. Through its service-as-a-service model hosted on the public cloud, RootCloud supports clients in enhancing product quality and reinforcing core competencies.
TSC Laser Technology Development (Beijing) Co., Ltd. provides 3D printing services. The firm is headquartered in China.
Ninebot Inc. is a Beijing-based company that specializes in the design, development, manufacturing, distribution, and sale of short-distance personal transportation products. Founded in 2012 by Gao Lufeng, Ninebot focuses on eco-friendly, electric, and self-balancing vehicles aimed at enhancing short-range commuting. The company operates through a network of distributors and retail points, serving customers both in China and internationally.
Novogene Co., Ltd. is a global leader in genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics. Established in 2011 and headquartered in Beijing, the company offers a wide range of genomic services, including human genome sequencing, cancer genomic profiling, and microbial genome sequencing, among others. Novogene also provides clinical-grade sequencing services and innovative diagnostic tools such as NovoFocus, designed for PARP inhibitor therapies, and NovoNeoantigen, which identifies cancer neoantigens from paired tumor-normal samples. With a workforce of approximately 1,800 employees and multiple global locations, Novogene boasts the largest sequencing capacity worldwide. The company has made significant contributions to the field, holding 49 NGS-related patents and facilitating the publication of over 1,850 research papers in prestigious journals. Founder Dr. Ruiqiang Li, a prominent figure in genomics, has been instrumental in advancing the company's capabilities and expertise, emphasizing the integration of sequencing and informatics to accelerate scientific progress for its clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.